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S6K1inase 1 (S6K1) is emerging as a common downstream target of signalling by
hormones and nutrients such as insulin and amino acids. Here, we have investigated how amino acids signal
through the S6K1 pathway. First, we found that a commercial anti-phospho-Thr389-S6K1 antibody detects
an 80–90 kDa protein that is rapidly phosphorylated in response to amino acids. Unexpectedly, this
phosphorylation was insensitive to both mTOR and PI-3 kinase inhibitors, and knockdown experiments
showed that this protein was not S6K1. Looking for candidate targets of this phosphorylation, we found that
amino acids stimulated phosphorylation of RSK and MSK kinases at residues that are homologous to Thr389
in S6K1. In turn, these phosphorylations required the activity of either p38 or ERK MAP kinases, which could
compensate for each other. Moreover, we show that these MAP kinases are also needed for the amino acid-
induced phosphorylation of S6K1 at Thr421/Ser424, as well as for that of S6K1 substrate, the S6 ribosomal
protein. Consistent with these results, concomitant inhibition of p38 and ERK pathways also antagonised the
well-known effects of amino acids on the process of autophagy. Altogether, these ﬁndings demonstrate a
previously unknown role for MAP kinases in amino acid signalling.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cell growth is a fundamental biological process through which
cells accumulate mass and increase in size. This process is modulated
by the availability of nutrients. In eukaryotic cells, the Ser/Thr kinase
mTOR controls cell size in response to nutrients. In metazoans,
insulin/IGF (insulin-like growth factor) controls cell and organismal
growth by modulating mTOR signalling. mTOR forms two distinct
multiprotein complexes, mTORC1 and mTORC2, which can be
distinguished by their sensitivity to the drug rapamycin. Rapamycin-
sensitive mTORC1 regulates several pathways that collectively
determine cell mass, whereas rapamycin-insensitive mTORC2 reg-
ulates cell shape via changes in the actin cytoskeleton [1,2].
The insulin pathway components leading to mTORC1 have been
well established. Insulin binding to its receptor causes an increase in
tyrosine phosphorylation of IRS1/2 (insulin receptor substrate 1/2).
These phosphorylated residues in IRS1/2 serve in turn as docking sites
for phosphoinositide 3-kinase (PI3K), whose binding leads to an
increase in the plasma membrane levels of phosphatidylinositol-
3,4,5-P3 (PIP3). As a result of increased PIP3 levels, protein kinase Bin; S6K1, Ribosomal protein S6
n- and stress-activated protein
3β, Glycogen synthase kinase
tivated protein kinase; siRNAs,
l rights reserved.(PKB/Akt) and phosphoinositide-dependent protein kinase 1 (PDK1)
are also recruited to the plasma membrane. PDK1 can then activate
PKB/Akt by phosphorylating it at T308. Activated PKB/Akt then
phosphorylates and inactivates Tuberous Sclerosis Complex protein
2 (TSC2). Since TSC2 negatively regulates the small GTPase Rheb (Ras
homolog enriched in brain), TSC2 inactivation by PKB/Akt leads to an
accumulation of the active GTP-bound form of Rheb. This active form
directly activates mTORC1 and induces the phosphorylation of its
substrates: S6K1 and 4EBP-1 [2,3].
The importance of nutrients in mTOR signalling was evidenced by
studies on autophagy. These initial studies showed that amino acids
inhibited autophagy and activated S6K1 [4]. Furthermore, it was
shown that S6K1 activation was dependent on mTOR activity [5].
Activation of S6K1 involves the phosphorylation of multiple Ser/Thr
residues. Of these, Thr389 (T389) phosphorylation, which is mediated
by mTORC1, appears to be a critical step in S6K1 activation [6–9].
Speciﬁc antibodies against this phosphorylated residue have been a
valuable tool to analyse S6K1 activation. In fact, it was with these
reagents that amino acid-induced S6K1 phosphorylation at T389 was
initially described [10]. Although the signalling components that
mediate mTOR activation in response to nutrients are still poorly
deﬁned, it seems that hVps34, a class 3 PI3K, and MAP4K3 are in-
volved in mTOR activation by amino acids [3,10–12].
Critical cellular processes such as proliferation, migration and
differentiation are regulated by extracellular signals including
growth factors, stresses and cytokines. Intracellularly, cells need to
integrate the extent and timing of these signals to trigger an appro-
priate biological response. Many of these signals act via speciﬁc
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biochemical events in which mitogen-activated protein kinases
(MAPKs), such as ERK (extracellular signal-regulated kinase) or
p38, often play very important roles. In addition to activating
transcription factors, these kinases also phosphorylate and activate
other groups of kinases, including the mitogen- and stress-activated
kinases MSK1 and MSK2, and the p90 ribosomal S6 kinases RSK1,
RSK2, RSK3 and RSK4. Several studies have shown that, while MSKs
can be activated by both p38 and ERK, RSKs are exclusively activated
by ERK. These kinases, through phosphorylation of a wide variety of
substrates, regulate important cellular functions. RSKs control
transcription, cell proliferation, cell survival, cytoskeletal rearrange-
ments and glycogen metabolism. MSKs activate transcription factors,
such as CREB and ATF1, and induce chromatin remodelling. In spite
of the many cellular functions identiﬁed so far for both MSKs and
RSKs, nothing has yet been published involving these kinases in
amino acid signalling [13,14].
In the present study, we uncover new players and mechanisms
involved in amino acid signalling. First of all, we found that the anti-
P-T389-S6K1 antibody detects a previously unreported protein of
approximately 85 kDa. In response to amino acids, this protein was
rapidly phosphorylated and translocated from cytoplasm to nucleus.
This phosphorylation was insensitive to both rapamycin and
wortmannin. Experiments of siRNA showed that this protein was
not S6K1. Instead, we found that amino acids stimulated phosphor-
ylation of RSK and MSK at residues homologous to S6K1-T389. These
phosphorylations required the activity of either p38 MAPK or, in its
absence, the activity of ERK. Finally, we show that p38/ERK MAP
kinases also regulated S6K1 phosphorylation at T421/S424 with a
similar mechanism. Physiological implications of this signalling are
shown and discussed.
2. Materials and methods
2.1. Reagents
The reagents used were insulin, wortmannin, rapamycin, betaine,
γ-amino-n-butyric acid (AIB), glycine, Phalloidin-TRITC, horseradish
peroxidase-coupled secondary antibodies, anti-Flag, anti-HA and
anti-P-ERK1/2 antibodies (Sigma-Aldrich); amino acid solutions
(MEM and MEM non-essential) (Gibco); L-glutamine solution
(Biological Industries); TO-PRO3 (Molecular Probes); U0126 and SB
203580 (Calbiochem); PMA (Biomol); anti-P-S9-GSK3β (Ab-1) anti-
body (Oncogene Research Products); anti-mTOR, anti-P-T389-S6K1
(1A5), anti-P-T421/S424-S6K1, anti-P-S380-RSK, anti-P-S376-MSK,
anti-P-S235/236-S6, anti-S6 (54D2), anti-P-S133-CREB and anti-P-
T180/Y182-p38 antibodies (Cell Signalling Technology); anti-TSC2 (C-
20), anti-S6K1 (C-18) and anti-RSK1 (C-21) antibodies (Santa Cruz
Biotechnology, Inc.); anti-HERC1 antibody [15], anti-LC3 antibody
(MBL); enhanced chemiluminescence (ECL Plus) reagent, PVDF
transfer membrane (GE Healthcare).
2.2. Cell culture and transfections
HeLa, HEK-293, HEK-293T and MCF-7 cells were cultured at 37 °C
in Dulbecco'smodiﬁed Eagle'smedium (DMEM) (Gibco) with 10% fetal
bovine serum. Plasmids were transfected with Lipofectamine 2000
(Invitrogen) in HeLa cells and with polyethylenimine (PEI) in HEK-293
or HEK-2933T cells. siRNA transfections were carried out in HeLa cells
with Lipofectamine 2000. Cell treatments such as serum starvation,
amino acid deprivation, insulin or amino acid stimulation were
performed as previously reported [5,10,16]. Brieﬂy, for experiments
with 200 nM insulin (I), cells were deprived of serum overnight and
then incubated with insulin for 30 min. For experiments with amino
acids (II), after overnight serum deprivation cells were incubated for
an additional 2 h with D-PBS (Dulbecco's phosphate-buffered salinecontaining 1000mg/l D-glucose and 36mg/l sodium pyruvate, calcium
andmagnesium) (Gibco). Cells were then stimulated with amino acids
(a mix of essential amino acids, non-essential amino acids and L-
glutamine solutions from Gibco and Biological Industries to 1× stock
ﬁnal concentration) for 30 min. The concentration of each amino acid
designated as 1× is as follows (in mg/l): L-Arg, 126; L-Cys, 24; L-His,
42; L-Ile, 52; L-Leu, 52; L-Lys, 73; L-Met, 15; L-Phe, 33; L-Thr, 48; L-Trp,
10; L-Tyr, 36; L-Val, 47; L-Ala, 9; L-Asn, 13; L-Asp, 13; L-Glu, 15; Gly, 7;
L-Pro, 11; L-Ser, 10; L-Gln, 292. The speciﬁc inhibitors were added 30–
60 min before the stimulation with amino acids or insulin at a ﬁnal
concentration of 20 nM rapamycin, 100 nM wortmannin, 5 μM U0126
and 10 μM SB 203580. PMA stimulation was performed as previously
reported [30].
2.3. Plasmids and siRNAs
Flag-p70 and Flag-p85 S6K1; HA-GST-p85; Flag-MSK1; HA-MSK2,
HA-S6K2, GST-S6; 3xFlag-RSK1, 3xFlag-RSK1-NA, 3xFlag-RSK2; and
activated MKK6 were kindly provided by Dr. B. Law, Dr D.M. Sabatini,
Dr. S. Arthur, Dr. J. Blenis, Dr. J.L. Maller and Dra. P. Muñoz-Canoves,
respectively. siRNAs were designed for targeting the human coding
sequence of S6K1 GGGGGCUAUGGAAAGGUUUdTdT, mTOR CCCUGC-
CUUUGUCAUGCCUdTdT and RSK1 GCUAUACCGUCGUGAGAUCdTdT.
2.4. Cell lysate and immunoblotting
Previously treated cells were lysed in lysis buffer (10 mM Tris–HCl,
pH 7.5, 100 mM NaCl, 1% Nonidet P40, 50 mM NaF, 1 mM sodium
vanadate, 1 mM phenylmethylsulfonyl ﬂuoride, 5 μg/ml leupeptin,
5 μg/ml aprotinin, 1 μg/ml pepstatin A, 20 mM β-glycerophosphate,
100 μg/ml benzamidine) for 1 h at 4 °C. Equal amounts of proteins
(100–200 μg/lane) were separated by electrophoresis. To analyse
simultaneously in the same SDS/PAGE gel giant proteins as HERC1 or
mTOR and small proteins as LC3, we used a combination of SDS/PAGE
gels named LAG gel [17]. After running overnight the gel, the proteins
were transferred to PVDF membranes and visualised by immunoblot-
ting as described previously [17]. Band intensities were analysed with
a gel documentation system (LAS-3000 Fujiﬁlm). The protein levels
were normalised with respect to mTOR or TSC2 levels and expressed
as percentage of controls.
2.5. Immunoprecipitations and kinase assay
Lysates from HEK-293T or HEK-293 cells were immunoprecipitated
with anti-mTOR or anti-RSK1 antibodies, respectively. Washed immu-
noprecipitates were used for in vitro kinase assay using puriﬁed HA-
GST-p85 or GST-S6 as substrate, respectively. For mTOR kinase assay:
lysis, immunoprecipitation, kinase assay and HA-GST-p85 puriﬁcation
were performed as described [18]. For RSK kinase assay: lysis and
immunoprecipitation were performed as described [18], and kinase
assay as described [30] using GST-S6 as substrate and anti-P-S235/236-
S6 antibodies to detect the incorporation of phosphate. Band intensities
were quantiﬁed with a gel documentation system (LAS-3000 Fujiﬁlm)
and results are expressed as mean±SEM from the control.
2.6. Confocal microscopy
HeLa cells were processed for immunoﬂuorescence analysis as
previously described [19] using anti-P-T389-S6K1 antibody (1:60),
Phalloidin-Texas red isothiocyanate (TRITC) (at 0.04 μg/ml) and To-
PRO3 (at 0.3 μM).
2.7. Statistical analysis
Results are expressed as mean±SEM. Data for multiple variable
comparisons were analysed by one-way analysis of variance (ANOVA).
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according to the statistical program GraphPad Prism.
3. Results
3.1. Anti-P-T389-S6K1 antibody detects a p85 S6K1-like protein that is
phosphorylated in response to amino acids in a rapamycin- and
wortmannin-independent manner
Previous reports suggest that amino acids mediate S6K1 activation
by inducing mTOR-mediated T389-S6K1 phosphorylation [5,8,10]. To
conﬁrm this point, we analysed by Western blot the activation ofFig. 1. Anti-P-T389-S6K1 antibody detects a p85 S6K1-like protein other than p70 S6K1 whi
(B–D) cells were deprived of serum overnight and stimulated with 200 nM insulin for 30 mi
stimulation with amino acids 1× for up to 30 min (II). Cell lysates were analysed by Wester
wortmannin or 20 nM rapamycin for 30 min before insulin or amino acid stimulation. Mol
independent experiments.endogenous S6K1 by amino acids using a commercial monoclonal
anti-P-T389-S6K1 antibody (1A5, Cell Signaling Technology). As a
model, we used HEK-293 and HeLa cells, because both cell lines have
extensively been used to analyse this signalling pathway. Before being
stimulated with amino acids, cells were ﬁrst deprived of serum
overnight, followed by an incubation in mediumwithout amino acids
[5,10,16]. As a positive control of S6K1 activation, cells deprived of
serum were stimulated with insulin. As shown in Fig. 1A, phosphor-
ylation of endogenous S6K1 isoforms, p70 and p85, was detected by
Western blot with anti-P-T389 antibody after 30 min of treatment
with insulin in HeLa cells. Unexpectedly, after 30 min of treatment
with amino acids, we detected an increase in a band with similarch is phosphorylated in response to amino acids. HeLa (A, B, D), MCF-7 (B) or HEK-293
n (I) or, after serum deprivation, they were deprived for 2 h of amino acids, followed by
n blot analysis with the indicated antibodies. (C, D) Cells were incubated with 100 nM
ecular weight markers are indicated on the left. These data are representative of three
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p70 phosphorylation. Sometimes, another band, less intense and with
a slower mobility than the p85-like band, was also detected after
longer exposure (not shown). Although these signals were clearly
detected (see also next ﬁgures), they were not strong probably
because we are detecting endogenous levels of these phosphorylated
proteins. These treatments did not modify endogenous levels of other
proteins involved in the mTOR signalling pathway, such as S6K1,
mTOR, TSC2, TSC1 or HERC1 (Fig. 1A and data not shown) [1–3,20].
These results were also observed in other cell lines such as HEK-293 or
MCF-7 (Fig. 1B). In order to conﬁrm these results, we repeated these
experiments in the presence of known inhibitors of S6K1 activation in
HEK-293 cells (Fig. 1C). These experiments conﬁrmed the speciﬁc
activation of this endogenous p85-like isoform of S6K1 by amino acids
and that this activation is independent of rapamycin and wortmannin,
known inhibitors of mTOR and PI3K and mTOR kinases, respectively
[41]. To show the functionality of these inhibitors, in parallel
experiments, cell stimulation by insulin conﬁrmed the previously
reported inhibition of S6K1 phosphorylation (p70 and p85 isoforms)
by wortmannin and rapamycin [1–3] (Fig. 1C). Similar results were
also obtained in HeLa cells (Fig. 1D). In Fig. 1D, “II” indicates
experiments with cells previously depleted of both serum and
amino acids, whereas “I” indicates cells previously depleted of
serum but not of amino acids. Under these conditions, the simulta-
neous stimulation with amino acids and insulin did not increase the
phosphorylation of endogenous p85-like protein indicating that this
phosphorylation is independent of the presence of insulin (Fig. 1D,
experiments II).
As a control of amino acid action, we analysed the protein levels of
autophagy marker LC3-II [21]. The presence of amino acids but not
insulin inhibited the autophagy previously induced by cell starvation
(Fig.1C). In these conditions, autophagy inhibitionwas independent of
rapamycin.
3.2. Time-course of amino acid-induced phosphorylation and nuclear
translocation of the p85 S6K1-like protein
Next, we analysed the timing of p85-like protein phosphorylation
in response to amino acids. We did this using both Western blot and
immunoﬂuorescence microscopy with the anti-P-T389-S6K1 anti-
body. These experiments indicated that the p85-like protein is
phosphorylated very rapidly (1–5 min) after amino acid treatment
(Fig. 2). Moreover, p85-like protein phosphorylation in the cytosol was
followed by its translocation to the nucleus, which was clearly
detected after 15 min (Fig. 2B). This effect was transient, since
incubation with complete medium signiﬁcantly restored the original
subcellular distribution (Fig. 2B).
3.3. Amino acid signalling is not mediated by endogenous S6K1
phosphorylation at T389
S6K1 (RPS6KB1) gene encodes a transcript with two alternative
translation starts resulting in the generation of p85 (α1) and p70
(α2) isoforms. p70 is identical to p85 in its amino acid sequence
except for the fact that it lacks the N-terminal 23 amino acids, which
contain a nuclear localisation signal (Fig. 3A). Thus, p85 has been
described to localise in the nucleus while p70 appears predominantly
in the cytoplasm [22,23]. With this in mind, the above data seem to
indicate that the p85 isoform of S6K1 was phosphorylated by the
presence of amino acids. To conﬁrm this hypothesis, we transfected
HEK-293 cells with S6K1 isoforms labelled with the Flag-epitope
[24]. Treatment with insulin conﬁrmed the functionality of the Flag-
p70 and Flag-p85 constructs (Fig. 3B). Treatment with amino acids
did not induce the phosphorylation of either Flag-p85 or Flag-p70,
but it still phosphorylated the endogenous p85-like protein (Fig. 3B).
A second S6 kinase gene exists, S6K2 (RPS6KB2), which is known tobe highly similar to the S6K1 gene [3]. We have also analysed the
putative regulation by amino acids of the S6K2 protein using
transfected cells with HA-S6K2 [36]. Similar to S6K1, treatment
with amino acids did not induce the phosphorylation of HA-S6K2
(Fig. 3C). The functionality of the HA-S6K2 construct was conﬁrmed
by its phosphorylation after treatment with insulin (Fig. 3C). These
results suggested that the phosphorylated band detected with anti-P-
T389-S6K1 antibody after treatment with amino acids is not S6K1 or
S6K2 proteins. To conﬁrm this point, HeLa cells were transfected with
small interfering RNAs (siRNAs) targeting S6K1 or mTOR, as well as
with control siRNA. The siRNA treatment resulted in a N95%
knockdown of S6K1 or mTOR expression (Fig. 3D). In these cells,
treatment with amino acids still induced the phosphorylation of the
p85-like protein detected by the anti-P-T389-S6K1 antibody, in a
manner independent of S6K1 or mTOR expression (Fig. 3D). As
control, knockdown of the autophagy inhibitor mTOR produced an
increment in LC3 levels (Fig. 3D), as expected [2]. Altogether, these
results show that, under these conditions, amino acids did not
stimulate detectable phosphorylation of endogenous S6K1 at T389
and that the anti-P-T389-S6K1 antibody is probably detecting
another related protein.
These ﬁndings differ from previous reports describing the T389
phosphorylation of S6K1 by amino acids [8,10,12]. Although we must
keep in mind the different experimental conditions used in some
experiments, the cross-reaction of the anti-P-T389-S6K1 antibody
could explain some of these differences. Some of these reports also
used an in vitro kinase assay and puriﬁed HA-GST-S6K1 protein as
substrate to show the mTOR activation [8,12]. To clarify this point, we
used a similar in vitro kinase assay to examine if mTOR was activated
by amino acids under these conditions. As shown in Fig. 3D, mTOR
immunoprecipitated from amino acid-starved cells phosphorylated
the puriﬁed substrate HA-GST-S6K1 at T389. This phosphorylation
was increased when the substrate was incubated with mTOR
immunoprecipitated from cells stimulated with amino acids. As
negative control, the kinase assay with mTOR immunoprecipitated
from cells stimulated was performed in the absence of ATP. These
ﬁndings conﬁrmed previous reports [8,12]. In order to reconcile all
these results, a possible explanation is that incubation with amino
acids activates the kinase activity of mTOR, as demonstrated by the in
vitro assays with high levels of substrate (Fig. 3E, slight but
signiﬁcantly activation of mTOR: 1.67±0.26 fold), but in vivo this is
not enough to phosphorylate endogenous S6K1 at T389 (Figs. 1–3). In
agreement with this, we did not observe amino acid-induced
phosphorylation at Thr37/46 of endogenous 4EBP1 protein, another
mTOR substrate (data not shown), conﬁrming previous results [16].
With this rationale, one would think that, if S6K1 could be over-
expressed to higher levels, thenmaybe a fraction of this proteinwould
become an in vivo substrate of mTOR. To check this, we used HEK-
293T cells in place of HEK-293 or HeLa cells because HEK-293T cells
contain the SV40 T antigen that allows for ampliﬁcation of transfected
plasmids containing the SV40 origin of replication. Using these cells, a
small fraction of overexpressed Flag-p85 S6K1 was phosphorylated at
T389 after treatment with amino acids (Fig. 3F). Moreover, SV40
transformation activates PI3K and Akt kinases [37,38]. Thus, S6K1
overexpression and/or PI3K/Akt activation could also explain some
previous reports of mTOR activation by amino acids and their
discrepancy with these results.
3.4. Phosphorylation of RSK and MSK is involved in amino acid signalling
The fact that amino acid signalling was not mediated by S6K1/
S6K2 phosphorylation at T389 led us to focus upon other candidates.
To do this, we took the sequence surrounding S6K1 T389 residue and
looked for other proteins with similar sequences which could be
candidates to be detected by the anti-P-T389-S6K1 antibody.
Members of the AGC family of serine/threonine protein kinases
Fig. 2. Time-course of stimulationwith amino acids. HEK-293 (A) or HeLa (B) cells were deprived of serum and amino acids, and then stimulated with amino acids as described in Fig.
1 at different times. (A) Cell lysates were analysed byWestern blot analysis with the indicated antibodies. Molecular weightmarkers are indicated on the left. (B) Staining with anti-P-
T389-S6K1 antibody, Phalloidin-TRITC (F-actin staining) and TO-PRO3 (nuclear staining) was carried out as indicated in Materials and methods. For recovery, after 30 min, cells were
washed and incubated with complete medium for 1 h.
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with this region (Fig. 4A). Moreover, these proteins have an
electrophoretic mobility similar to p85 and their regulation occurs
independently of mTOR. In particular, a serine residue within the
hydrophobic motif of the RSK and MSK family members could be the
target of the anti-P-T389-S6K1 antibody [13]. To check this hypo-
thesis, we transfected HEK-293 cells with a member of each of
these families tagged with Flag-epitopes. As shown in Fig. 4B, C,
phosphorylation of Flag-RSK1 or Flag-MSK1 was detected with anti-
P-T389-S6K1 antibody after stimulation with amino acids. To show
that this phosphorylation occurs at the serine of its hydrophobic
motif, we also transfected a non active (NA) mutant form of RSK1
obtained by replacing S380 by lysine [25]. As shown in Fig. 4B, this
mutant was not detected by anti-P-T389-S6K1 antibody, indicating
that phosphorylation of RSK1 at S380 is necessary for its detection
using this antibody. These results are not exclusive for RSK1 or MSK1
because other members of these families, such as RSK2 or MSK2,were also detected phosphorylated after stimulation with amino
acids (Fig. 4C and data not shown). To conﬁrm that these proteins are
involved in amino acid signalling, we performed siRNA experiments.
Knockdown of RSK1 clearly inhibited the amino acid-induced
phosphorylation detected with the anti-P-T389-S6K1 antibody (Fig.
4D). As a positive control, RSK1 knockdown also led to a decrease in
the phosphorylation of glycogen synthase kinase 3β (GSK3β), a
known RSK substrate [13] (Fig. 4D). In parallel experiments, knock-
down of S6K1 did not affect any of these phosphorylations (Fig. 4D).
Although a complete elimination of the phosphorylation detected
with the anti-P-T389-S6K1 antibody would probably require the
simultaneous knockdown of all RSK (RSK1–4) and/or MSK (MSK1–2)
expressed in these cells, the observed reductions in amino acid-
induced phosphorylations as a result of RSK1 knockdown strongly
suggest that RSK1 is a major target of amino acid signalling (Fig. 4D).
Interestingly, it has been demonstrated that whereas MSK is
restricted to the nucleus, RSK is abundant in the cytoplasm and,
Fig. 3. Amino acid signalling is not mediated by S6K1 phosphorylation at T389. (A) Structure and sequence of human S6K1 protein. Two alternative translation starts result in the
generation of p85 and p70 isoforms. p70 lacks the N-terminal 23 amino acids (underlined), which contain a nuclear localisation signal. The threonine recognised by the antibody
(T389 in p70 or T412 in p85) is indicated and circled. (B) HEK-293 cells were transfected 24 h before serum deprivation with Flag-p70 S6K1 or Flag-p85 S6K1. (C) HeLa cells were
transfected 24 h before serum deprivation with HA-S6K2 or Flag-p70. (D) HeLa cells were transfected with the indicated siRNAs 48 h before serum deprivation. Amino acid
deprivation, stimulation andWestern blot analysis in B–Dwere similar to what has been described in Fig. 1. (E) In vitro kinase assay using mTOR immunoprecipitates (IP) as source of
mTOR-containing complexes and HA-GST-S6K1 as substrate. Lysates fromHEK-293T cells deprived of serum and amino acids and then stimulated or not with amino acids for 30 min
(PNS) were immunoprecipitated with anti-mTOR antibodies. Immunocomplexes were resuspended in kinase buffer and incubated with puriﬁed HA-GST-S6K1 in the presence or
absence of ATP during 30min at 37 °C. Reactions were stopped in ice with SDS/PAGE buffer and analysed by immunoblotting for phosphorylation on T389 using the anti-P-T389-S6K1
antibody and for substrate levels using an anti-HA antibody. Levels of TSC1 and TSC2 proteins were used as control of lysates. HA-GST-S6K1 substrate was previously expressed in and
puriﬁed from HEK-293T cells. We have quantiﬁed this kinase activity from three independent experiments observing a signiﬁcant activation of mTOR in the presence of amino acids
(1.67±0.26 fold of activation). (F) Overexpression of S6K1 in HEK-293T. Cells were transfected 24 h before serum deprivationwith Flag-p85 S6K1. Amino acid deprivation, stimulation
and Western blot analysis were as described in Fig. 1. These data are representative of at least three independent experiments.
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data and our ﬁndings suggest that the translocating protein observed
in the confocal immunostaining analysis (Fig. 2B) is RSK.Collectively, the above results point to the fact that phosphoryla-
tion of RSK and MSK proteins mediates signalling by amino acids.
However, one could still argue that all these results have been found
Fig. 4. Amino acid signalling is mediated by phosphorylation of RSK andMSK. (A) Structure of human RSK1 (NTK: N-terminal kinase domain; CTK: C-terminal kinase domain) and its
phosphorylation sites. Sequence comparison between the region encompassing amino acid residues T389/412 of S6K1 and similar regions in MSK and RSK family kinases. The serine
in the hydrophobic motif of RSK andMSK families is underlined. (B, C) HEK-293 cells were transfected 24 h before serum deprivationwith the indicated plasmids. (D) HeLa cells were
transfected with the indicated siRNAs 48 h before serum deprivation. Amino acid deprivation, stimulation and Western blot analysis in B–D were as described in Fig. 1. Histograms
from experiments in B–D (n=3). All bands were normalised with respect tomTOR or TSC2 levels. Data represent the ratio of P-T389-S6K1 in different conditions, and are expressed as
the mean±SEM of percentage of respective control.
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point, we have used commercial phospho-speciﬁc antibodies against
the equivalent residues to S6K1-T389: S380 (for RSK) and S376 (for
MSK). In Fig. 5A, it is shown how these antibodies detected the
phosphorylation of endogenous RSK and MSK proteins after stimula-
tion with amino acids (lane 6). As expected, insulin did not stimulate
these phosphorylations (lane 4), in agreement with previous publica-
tions [2,3]. In this context, in vitro kinase assays using GST-S6 fusion
protein as substrate conﬁrmed the activation of endogenous RSK by
amino acids (Fig. 6).3.5. ERK and p38 pathways regulate amino acid signalling
RSK proteins have been described to be activated by MAP kinases
of the extracellular signal-regulated kinase (ERK) family in response
to different stimuli such as growth factors, hormones or neuro-
transmitters [13]. MSK proteins have also been described to be
activated by ERK in response to such stimuli, as well as by the p38
MAP kinase family in response to several cellular stress stimuli and
proinﬂammatory factors [13]. To analyse these regulatory MAP
kinases, speciﬁc antibodies against their phosphorylated forms are
Fig. 5. ERK and p38 pathways mediate the amino acid-induced phosphorylation of RSK and MSK. HEK-293 (A) or HeLa (B) cells were deprived of serum and amino acids. Stimulation
andWestern blot analysis were carried out as described in Fig. 1. Where indicated, cells were incubated with 5 μMU0126 (U), 10 μM SB 203580 (S), 100 nMwortmannin (W) or 20 nM
rapamycin (R) for 60 min before insulin or amino acid stimulation. NSB: nonspeciﬁc band recognised by the antibody. (C) Histograms from experiments in B (n=3). All bands were
normalised with respect to mTOR levels. Data represent the ratio of P-T180/Y182-p38, P-ERK1/2, P-S376-MSK and P-S380-RSK, and are expressed as the mean±SEM of percentage of
respective control. Statistical analysis was carried out as indicated in Materials and methods. ⁎⁎⁎pb0.001.
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antibodies to analyse their putative activation during amino acid
signalling. As it is shown in Fig. 5A (lanes 5–6), p38 was
phosphorylated upon stimulation with amino acids. Interestingly,
ERK proteins were phosphorylated in the starved state (Fig. 5A, lane
5) previous to amino acid stimulation, while amino acid treatment
decreased this phosphorylation (Fig. 5A, lane 6). Because there is no
phosphorylation of RSK or MSK in the starved state, these results
seem to rule out the possibility that ERK are responsible for the
amino acid-induced phosphorylation of RSK and MSK. On the other
hand, the observed activation of p38 by amino acids points to this
protein as a good candidate to mediate RSK and MSK phosphoryla-
tion. The speciﬁcity of these phosphorylations was checked by
stimulation with insulin. As expected, only ERK proteins were
phosphorylated (Fig. 5A, lane 4). To elucidate the roles of these
kinases, we have used speciﬁc inhibitors of their respective path-
ways: U0126, an inhibitor of ERK phosphorylation, and SB 203580,
which blocks p38 activity. Interestingly, only when both inhibitors
were simultaneously used were RSK and MSK phosphorylation
completely inhibited (Fig. 5A, lane 12). This suggests a compensatory
mechanism whereby ERK would mediate RSK and MSK phosphor-
ylation when p38 is inactive, while p38 would assume this role inthe absence of a functional ERK. It has been previously reported that
p38 signalling exerts an inhibitory effect on ERK signalling [40]. This
could also explain why ERK phosphorylation is stimulated by amino
acids in the presence of SB 203580 (Fig. 5A, lane 10). Under these
conditions, the presence of rapamycin or wortmannin did not
signiﬁcantly affect to the phosphorylations of ERK, p38, RSK or
MSK proteins (Fig. 5B, C).
To determine the signiﬁcance of these MAP kinases and their
downstream targets in the amino acid signalling, we have compared
the phosphorylation of these kinases in cells treated with a strong
inducer of the ERK signalling. Stimulation of cells with the phorbol
esther PMA, which stimulates Ras/ERK but not PI3K/Akt signalling,
resulted in an induction of ERK, p38, RSK and MSK activation, and
the phosphorylation of S6 (at S235/S236), CREB (at S133) and GSK3β
(at Ser 9) known substrates of S6K/RSK, MSK and RSK, respectively
(Fig. 7). Interestingly, ERK phosphorylation was observed only with
PMA addition (with amino acids there is an inhibition of its previous
phosphorylation by amino acid deprivation. See also Fig. 5). Thus,
these data indicate a substantial signalling by amino acids and,
although the upstream mechanism seems to be different, there is a
convergence of the signalling in RSK and MSK proteins upon
stimulation of cells by PMA or amino acids.
Fig. 6. Amino acids stimulate in vitro RSK activity. Amino acid deprivation, stimulation and Western blot analysis in A and B were similar to what has been described in Fig. 1.
Postnuclear supernatants (PNS) from HEK-293 cells deprived of serum and amino acids and then stimulated or not with amino acids for 30 minwere immunoprecipitated with anti-
RSK antibodies. (B) In vitro kinase assay using RSK immunoprecipitates (IP) as source of RSK-containing complexes and puriﬁed GST-S6 as substrate. Immunocomplexes were
resuspended in kinase buffer and incubated with puriﬁed GST-S6 in the presence or absence of ATP during 15 min at 30 °C. Reactions were stopped in ice with SDS/PAGE buffer and
analysed by immunoblotting for phosphorylation on S235/S236 using the anti-P-S235/S236-S6 antibody (A, B) and for substrate levels using an anti-GST antibody (B). Histograms
from experiment in B (n=4). All bands were normalised with respect to GST-S6 substrate levels. Data represent the ratio of P-S235/S236-GST-S6 phosphorylation and are expressed as
the mean±SEM of percentage of respective control. Statistical analysis was carried out as indicated in Materials and methods. ⁎⁎⁎pb0.001. Levels of mTOR and TSC2 proteins were
used as control of lysates. GST-S6 substrate was previously expressed in and puriﬁed from E. coli.
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by amino acids using a kinase assay [5,26]. Although our results
show that endogenous S6K1 is not phosphorylated at T389 after
stimulation by amino acids, they do not rule out the possibility thatFig. 7. Comparison of signalling by amino acids and PMA on ERK and p38 pathways. HeLa cell
deprivation, theywere deprived for 2 h of amino acids, followed by stimulationwith amino ac
antibodies. Molecular weightmarkers are indicated on the left. NSB: nonspeciﬁc band recogn
represent the ratio of P-T180/Y182-p38, P-ERK1/2, P-S376-MSK, P-S380-RSK, P-S235/S236-S
respective control (amino acid stimulation except for ERK which was amino acid depletionamino acid signalling can induce S6K1 activation through phosphor-
ylation at residues other than T389 [1–3,27]. The results above and
previously reported studies describing the S6K1 phosphorylation at
T421/S424 after the stimulation with EGF or amino acids [28,29], leds were deprived of serum overnight and stimulated with PMA for 30 min or, after serum
ids 1× for 30min. Cell lysates were analysed byWestern blot analysis with the indicated
ised by the antibody. All bands were normalised with respect tomTOR levels. Data (n=3)
6, P-S133-CREB and P-S9-GSK3β and are expressed as the mean±SEM of percentage of
condition).
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antibody. As shown in Fig. 8A (lanes 4–5), amino acids stimulated
the S6K1 phosphorylation at T421/S424, in agreement with Fumarola
et al. [29]. Interestingly, the main phosphorylation was at the p70
isoform of S6K1, which was easily observable when these samples
were analysed in parallel with other samples stimulated with insulin
(Fig. 8A, lane 4 versus lane 6). This comparison also revealed that
p70 S6K1 phosphorylation at T421/S424 is stimulated more strongly
by insulin than it is by amino acids. In order to examine whether
MAP kinases play a regulatory role in this phosphorylation, we used
the above speciﬁc inhibitors U0126 and SB 203580 of ERK and p38
pathways, respectively. As shown in Fig. 8A (lanes 5–12), only when
both inhibitors were used simultaneously was S6K1 phosphorylation
at T421/S424 completely inhibited (lane 12). To analyse if this
phosphorylation is regulated by rapamycin and/or wortmannin, weFig. 8. ERK and p38 pathways mediate the amino acid-induced phosphorylation of S6K1 a
Stimulation and Western blot analysis were performed as described in Fig. 1. Where indicate
(W) or 20 nM rapamycin (R) for 60min before insulin or amino acid stimulation. (C) Histogram
Data represent the ratio of P-T421/S424-S6K1 and P-S235/S236-S6, and are expressed as th
indicated in Materials and methods. ⁎⁎⁎pb0.001; ⁎⁎pb0.01.performed similar experiments in the presence of these inhibitors.
As shown in Fig. 8B, C, stimulation of S6K1 phosphorylation at T421/
S424 by amino acids is only dependent on ERK/p38 activities. To
assess the functional consequences of this phosphorylation, we also
measured the phosphorylation of the ribosomal S6 protein, substrate
of S6K1 activity. S6 phosphorylation was clearly stimulated by amino
acids in a manner dependent on ERK/p38 activities (Figs. 8B, C and
6A). In this case, we also detected a partial inhibition of S6
phosphorylation by the ERK inhibitor U0126. Although this inhibi-
tion was lower than that obtained in the presence of both ERK and
p38 inhibitors, these results might indicate the involvement of
another ERK-regulated kinase in S6 phosphorylation, as has been
reported with growth factors or serum [30].
Osmotic stress has been reported to activate p38 and inhibits ERK
[39]. These effects are similar to described here for amino acids. Int T421/S424. HEK-293 (A) or HeLa (B) cells were deprived of serum and amino acids.
d, cells were incubated with 5 μM U0126 (U), 10 μM SB 203580 (S), 100 nM wortmannin
s from experiments in B (n=3). All bands were normalised with respect to mTOR levels.
e mean±SEM of percentage of respective control. Statistical analysis was carried out as
Fig. 9. Amino acid signalling is not due to osmotic stress but to a speciﬁc effect of amino acids through p38 pathway. HeLa cells were deprived of serum and amino acids. Stimulation
andWestern blot analysis were performed as described in Fig. 1. (A) Where indicated, cells were stimulated for 30 minwith different osmolytes (Betaine and AIB-γ-amino-n-butyric
acid-) or amino acids (Gln, Gly or amino acids) to a ﬁnal concentration of 10 mM. Levels of mTOR, TSC2, S6K1 and S6 proteins were used as control of lysates. Only amino acid effect
was signiﬁcant. (B) Cells were transfected with the p38 activator MKK6 and the control pcDNA3 24 h before serum deprivation. Where indicated, cells were incubated with 10 μM SB
203580 for 60 min before stimulation with amino acids. Levels of mTOR, TSC2 and S6K1 proteins were used as control of lysates. All bands were normalised with respect to mTOR
levels. Histograms from experiments in A and B (n=3) represent the ratio of P-T180/Y182-p38, P-ERK1/2, P-T421/S424-S6K1 and P-S235/S236-S6 and are expressed as themean±SEM
of percentage of respective control.
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osmotic stress signalling, we have performed experiments in the
presence of non-nutrient osmolytes such as betaine or γ-amino-n-
butyric acid (AIB), and of amino acids such as Gly or Gln to a molar
concentration similar to the total concentration of the amino acids in
previous experiments. As shown in Fig. 9A neither of these molecules
could reproduce the regulation induced by all amino acids in p38, ERK,
S6K1 or S6.
The involvement of p38 pathway in the signalling by amino acids
led us to ask us if constitutive activation of this pathway would be
enough to activate S6 phosphorylation. To this end, we used a
constitutive active form of MKK6, which phosphorylates and activates
p38, and analysed cell extracts from HeLa after amino acid depletion.
Under these conditions, activation of p38 by MKK6 expression was
enough to activate S6K1 (T421/S424) and S6 (S235/S236) (Fig. 9B).
This effect was completely blocked by the p38 inhibitor SB 203580
(Fig. 9B).
The stimulation of autophagy by amino acid depletion and its
inhibitionwhen these nutrients were re-added was one of the earliestphysiological observations in the ﬁeld of amino acid signalling [31].
Figs. 1C and 2A conﬁrmed these observations using an LC3-based
assay for monitoring autophagy [21]. To analyse whether ERK and p38
pathways are involved in the autophagy regulated by amino acids, we
used the speciﬁc inhibitors U0126 and SB 203580 of ERK and p38,
respectively. As shown in Fig. 10, the presence of amino acids inhibited
the autophagy produced by starvation and only when both inhibitors
were used simultaneously was autophagy signiﬁcantly less inhibited
(LC3-II levels). In parallel experiments, rapamycin or wortmannin did
not affect the amino acid-induced autophagy inhibition. Inhibitors did
not affect autophagy induced by amino acid depletion (Fig. 10B).
4. Discussion
The mTOR pathway has an essential role in the control of mam-
malian growth and development. Hormones such as insulin and
nutrients such as amino acids seem to mediate their cellular effects
through this pathway [1,2]. The kinase p70 S6K1 is a substrate of the
mTOR kinase and it is commonly used as a reporter of mTOR activity.
Fig. 10. ERK and p38 pathways are involved in the regulation of autophagy by amino acids. (A) HEK-293 cells were deprived of serum and amino acids. Stimulation andWestern blot
analysis were carried out as described in Fig. 1. Where indicated, cells were incubated with 5 μMU0126 (U), 10 μMSB 203580 (S), 100 nMwortmannin (W) or 20 nM rapamycin (R) for
60min before insulin or amino acid stimulation. (B) Depleted cells were incubatedwith inhibitors as in A. Stimulation andWestern blot analysiswere carried out as described in Fig.1.
(C) Histograms from experiments in A (n=5). All bands were normalised with respect to mTOR levels. Data represent the ratio of LC3-II levels and are expressed as the mean±SEM of
percentage of respective control. Statistical analysis was carried out as indicated in Materials and methods. ⁎⁎⁎pb0.001.
2252 E. Casas-Terradellas et al. / Biochimica et Biophysica Acta 1783 (2008) 2241–2254Since it was demonstrated that mTOR phosphorylates p70 S6K1 at
T389 and that this phosphorylation plays an important physiological
role in insulin signalling, analysis of the T389 phosphorylation of p70
S6K1 with a commercial anti-phospho speciﬁc antibody has been
extensively used [1,2]. In this study, we set about using this
experimental approach to examine endogenous p70 S6K1 activation
by amino acids. Unexpectedly, however, by using the same commer-
cial anti-P-T389-S6K1 antibody, we detected the fast phosphorylation
of an endogenous 80–90 kDa protein. Remarkably, this phosphoryla-
tion was insensitive to both the mTOR inhibitor rapamycin and the
PI3K inhibitor wortmannin, indicating that the mTOR pathway is not
responsible for it (Fig.1). A possible explanation for these observations
was that the protein being phosphorylated was the less abundant p85
S6K1 isoform [22,23]. In order to test this hypothesis, we analysed
whether this isoform was phosphorylated at T412, equivalent to T389
of p70 S6K1, in response to amino acids. Transfection studies with
plasmids speciﬁcally expressing each of the S6K1 isoforms or even the
related S6K2 protein showed that none of them was the target of the
observed phosphorylation (Fig. 3B, C). This was conclusively demon-strated with the knockdown of both S6K1 isoforms (Fig. 3D), clearly
indicating that the anti-P-T389-S6K1 antibody recognises, upon
amino acid treatment, a protein that is neither p70 S6K1 nor p85
S6K1. These results are in contrast with those of others, who have
reported S6K1 T389 phosphorylation as a result of amino acid
signalling [3]. In some cases, the differences between our results
and those of previous studies can be explained by the different
experimental approaches used. For instance, in vitro kinase assays that
we performed showed that mTOR is slight activated by amino acid
treatment (Fig. 3E), in agreement with other studies [8,12]. Likewise,
we could also detect amino acid-induced phosphorylation of S6K1 at
T389, but only in experiments using overexpressed proteins (Fig. 3F,
[10]). In support of our results using endogenous proteins in HeLa,
HEK-293 andMCF-7 cells, studies in other cell types such as L6 muscle
cells, 3T3-L1 adipocytes and Fao hepatoma cells also showed the non-
T389 phosphorylation of S6K1 when cells were incubated with amino
acids in the absence of insulin [32].
Database searches for amino acid sequences that resembled the
one recognised by the anti-P-T389-S6K1 antibody in p70 S6K1 led us
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signalling targets. These proteins, like S6K1, are serine/threonine
protein kinases of the AGC family, they have an electrophoretic
mobility similar to that of p85 S6K1 and they are regulated
independently of mTOR [13]. Our results show that members of
these protein families are indeed recognised by anti-P-T389-S6K1
antibody when cells are stimulated with amino acids (Fig. 4). This
observation was very important because it led us to study the
regulation of amino acid signalling by MAP kinases. Activation of ERK
and p38 proteins has been shown to play a key role in the regulation of
cell growth, differentiation and cell stress [33]. The results presented
in this paper are compatible with a model in which amino acids exert
their effects at least partly by activating p38MAPK, or ERKwhenp38 is
inactive, and this in turn leads to activation of RSK and MSK kinases.
This observation is also very relevant because it involves p38 in the
activation of RSK proteins. Thus, we show that RSK proteins are
regulated by p38 or ERK proteins in a similarmanner towhat has been
described for MSK [13]. The fact that both p38 and ERK can
phosphorylate RSK and MSK reﬂects a robust cellular mechanism to
maintain RSK/MSK regulation by nutrients even when one of the
above MAPK cascades has been inactivated. Likewise, this functional
redundancy also explains why previous reports failed to identify the
role of MAPKs in amino acid signalling, since those reports used
speciﬁc inhibitors to only one of these kinases [5]. Interestingly, while
this manuscript was being written a paper was published describing
the regulation of RSK proteins by ERK and p38 in response to Toll-like
receptor activation in dendritic cells [34]. Thus, although a majority of
studies have shown that RSK is predominantly activated by ERK, these
studies evidence that p38 is also an activator of RSK.
The comparison between the stimulation of cells with the
phorbol esther PMA, an established ERK/RSK-MSK activator [13],
and with amino acids shows the efﬁcacy of the amino acid signalling
under these experimental conditions (Fig. 7). An interesting
observation of these ﬁndings was that, following amino acid
deprivation, ERK was activated (as revealed by increased ERK
phosphorylation) whereas their substrates, RSK and MSK, were not
activated. This unusual observation probably indicates an unknown
mechanism that impaired the activation of RSK and MSK by ERK
after amino acid deprivation. During the correction of this paper, it
has been also reported the activation of ERK followed to amino acid
deprivation in hepatoma cells requiring GCN2 kinase activity and
eIF2α phosphorylation [45].
The involvement of MAP kinases in amino acid signalling led us to
analyse the phosphorylation of S6K1 at other residues previously
shown to be regulated by MAP kinases [28]. Indeed, we could detect
S6K1 phosphorylation at T421/S424, in agreementwith previouswork
using the same anti-phospho antibody [29]. S6K1 phosphorylation at
T421/S424 correlated with an increase in the phosphorylation of
S6K1's substrate, the ribosomal S6 protein (Figs. 8 and 9). These
phosphorylations are regulated by p38 and ERK kinases. The amino
acid-stimulated S6 phosphorylation may be catalyzed by S6K1
phosphorylated at T421/S424 and T389 at undetectable levels and
RSK [42] (Fig. 6). The S6K1 activation by amino acids is compatible
with the convergent role assigned to S6K1 as a sensor of insulin- and
nutrient-mediated signalling [3,30].
Autophagy is stimulated in mammalian cells by nutrient depriva-
tion, which may act through mTOR repression or other as yet
undeﬁned mechanisms that activate class 3 PI3K in an mTOR-
independent manner [31]. The regulatory role of amino acids in
autophagy was initially reported in perfused rat liver, when
Mortimore and Schworer [35] showed the induction of autophagy
by amino acid deprivation. Since then, autophagy has been used as a
physiological indicator of amino acid signalling [31]. More recently,
MAP kinases ERK and p38 have been involved in the regulation of
autophagy in response to other stimuli [43,44]. Now, we show that
ERK and p38 kinases also mediate the regulation of autophagy byamino acids (Fig. 10). By contrast, our data using inhibitors of mTOR
and PI3K suggest that these two kinases are not involved in the
autophagy inhibition stimulated by amino acids after nutrient
deprivation. Although further studies will certainly be required in
order to fully understand the detailed mechanisms underlying amino
acid signalling and autophagy, we believe that the data shown here
represent a signiﬁcant step forward in this direction.
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